Search results

ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

Applications, Recent results, Publications.

At ACNS we currently have 13 instruments in our user program, which use a variety of scattering techniques to probe materials over a range of length scales.

Pamela Naidoo-Ameglio takes up executive role

The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.

Radiation can be described as energy or particles from a source that travel through space or other mediums. Light, heat, and wireless communications are all forms of radiation.

ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.

Griffith University researchers are conducting an experiment at ANSTO that will test a revolutionary physics theory that time reversal symmetry-breaking by neutrinos might cause a time dilation at the quantum scale.

His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of the Commonwealth of Australia and Her Excellency Mrs Linda Hurley visited ANSTO’s Innovation Centre nandin and several facilities including the OPAL multipurpose reactor this week for a tour after learning of the ANSTO-nandin win in the NASA SpaceApps COVID 19 Challenge.

Read about an ANSTO scientist and their work to prepare for a school project or interview.

Researchers from Murdoch University and associated collaborators are using ANSTO’s unique nuclear capabilities to gain detailed information about how wheat crops take in administered micronutrients to maximise their efficient use.